Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-21 4:28 pm Purchase | 13G | SUNSHINE BIOPHARMA INC SBFM | Altium Capital Management LP | 9,000,000 9.99% | 9,000,000 (New Position) | View |
| 2024-02-20 4:38 pm Purchase | 13G | EVOKE PHARMA INC EVOK | Altium Capital Management LP | 1,838,235 9.7% | 1,838,235 (New Position) | View |
| 2024-02-13 5:19 pm Purchase | 13G | VOLCON INC VLCN | Altium Capital Management LP | 1,666,665 9.9% | 1,666,665 (New Position) | View |
| 2024-02-13 5:17 pm Purchase | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | Altium Capital Management LP | 634,616 4.99% | 634,616 (New Position) | View |
| 2024-02-13 5:17 pm Unchanged | 13G | GRI BIO INC GRI | Altium Capital Management LP | 1,269,210 4.99% | 0 (Unchanged) | View |
| 2024-02-13 5:15 pm Unchanged | 13G | MARPAI INC MRAI | Altium Capital Management LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-13 5:10 pm Purchase | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LP | 8,027,593 6.2% | 1,529,675 (+23.54%) | View |
| 2024-02-13 3:47 pm Unchanged | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LP | 194,100 4.99% | 0 (Unchanged) | View |
| 2024-02-13 3:27 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LP | 2,660,000 5% | -324,803 (-10.88%) | View |
| 2024-02-02 6:09 pm Purchase | 13G | SKYE BIOSCIENCE INC SKYE | Altium Capital Management LP | 1,301,518 5.4% | 1,301,518 (New Position) | View |
| 2024-01-10 1:35 pm Purchase | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Altium Capital Management LP | 194,100 8% | 194,100 (New Position) | View |
| 2023-11-22 5:31 pm Purchase | 13G | VOLCON INC VLCN | Altium Capital Management LP | 2,800,000 9.9% | 2,800,000 (New Position) | View |
| 2023-08-23 06:01 am Purchase | 13G | ALIMERA SCIENCES INC ALIM | Altium Capital Management LP | 2,984,803 5.7% | 2,984,803 (New Position) | View |
| 2023-05-02 8:23 pm Purchase | 13G | GRI BIO INC GRI | Altium Capital Management LP | 1,269,210 9.99% | 1,269,210 (New Position) | View |
| 2023-04-26 5:18 pm Purchase | 13G | MARPAI INC MRAI | Altium Capital Management LP | 1,805,327 6.2% | 1,805,327 (New Position) | View |
| 2023-02-14 4:51 pm Unchanged | 13G | XTANT MED HLDGS INC XTNT | Altium Capital Management LP | 6,497,918 5.7% | 0 (Unchanged) | View |
| 2023-02-14 3:59 pm Unchanged | 13G | ASTRIA THERAPEUTICS INC ATXS | Altium Capital Management LP | 1,355,372 4.95% | 0 (Unchanged) | View |
| 2023-02-14 2:44 pm Sale | 13G | HYRECAR INC HYRE | Altium Capital Management LP | 1,688,120 5.6% | -48,795 (-2.81%) | View |
| 2023-02-14 2:35 pm Unchanged | 13G | SADOT GROUP INC SDOT | Altium Capital Management LP | 2,888,085 4.99% | 0 (Unchanged) | View |
| 2023-02-14 12:35 pm Sale | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Altium Capital Management LP | 0 0% | -333,333 (Position Closed) | View |